本文選題：肺血管擴張劑 + 肺動脈高壓��； 參考：《中華高血壓雜志》2017年04期

【摘要】：正肺動脈高壓(pulmonary arterial hypertension,PAH)患者使用肺血管擴張劑發(fā)生藥物不良反應(adverse drug events,ADEs)很常見。ADEs可能導致生活質(zhì)量下降;然而,它們與預后的關系未知。該研究的目的是確定開始皮下曲前列環(huán)素治療后常見的ADEs是否與PAH的預后相關。方法:納入來自4個PAH曲前列環(huán)素臨床試驗的受試者進行回顧性隊列研究,其中
[Abstract]:Adverse drug reactions with pulmonary vasodilator may lead to a decline in quality of life (QOL) in patients with pulmonary arterial hypertensioning. However, the relationship between ADEs and prognosis is unknown. The aim of this study was to determine whether common ADEs after subcutaneous triprostacyclin therapy was associated with the prognosis of PAH. Methods: a retrospective cohort study was conducted in four subjects from four PAH triprostacyclin clinical trials.
【分類號】：R544.1
，

本文編號：1826489